Infection

SAMPLE: Approximately what percentage of the total US population had an STI at a given point in 2018? Plus 6 more questions on STI trends based on the latest CDC data.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

A new review of >60 000 patients with diabetes found CGM use during the early weeks of the COVID-19 pandemic improved their time in range.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Global confirmed cases of COVID-19 have surpassed 109 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Global confirmed cases of COVID-19 have surpassed 108 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Double-masking found to reduce SARS-CoV-2 spread, FDA decision on antibody cocktail for treatment of COVID-19, and 8 more news briefs summarized for primary care.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

In the first study of its kind, pre-existing eosinophilia was protective from COVID-19-related hospital admission and mortality in patients with asthma.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

The FDA issued an EUA to Eli Lilly and Company for bamlanivimab and etesevimab administered together for the treatment of mild-to-moderate COVID-19.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

In the state with the highest COVID-19 death rate, 1 in every 406 residents has died; in the state with the lowest rate, the number is 1 in every 3436. Which states are they?

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Global confirmed cases of COVID-19 have surpassed 106 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Kaiser Family Foundation: New data from 23 states show consistently smaller shares of vaccination among Blacks vs Whites based on share of cases and deaths and of total population.

The submission is based on data from the phase 3 ENSEMBLE clinical trial that showed the investigational single-dose vaccine met all primary and key secondary endpoints.

Global confirmed cases of COVID-19 have surpassed 105 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Oxford researchers will evaluate the interchangeability of the vaccines, the impact of different dosing intervals, and the potential for enhanced immune response.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

A new primary analysis found that the AstraZeneca and University of Oxford COVID-19 vaccine is safe and effective at preventing infection and reducing transmission.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Global confirmed cases of COVID-19 have surpassed 103 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Will desire to return to “normal” life propel patients to get a COVID-19 vaccine? What do they think about efforts to contain transmission? Answers and more insights here.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Vaccines from both companies were significantly effective against COVID-19 and show promise against variants from the UK and South Africa.

US levels of SARS-CoV-2 circulation, associated illnesses, and deaths have been decreasing, but rising reporting delays due to holidays warrant caution.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Availability of the COVID-19 vaccine cannot come fast enough for many large US cities, based on the share in each of the most vulnerable populations.